Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-8309B (tandospirone) ophthalmic solution for geographic atrophy secondary to AMD
2008-007705-37Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tandospirone in age-related macular degeneration (AMD), geographic atrophy (GA), sponsored by Alcon Inc.. Started Mar 2009; status: completed.
02
Drugs
tandospirone
03
Conditions
age-related macular degeneration (AMD)geographic atrophy (GA)
Beyond the preview
Go deeper on 2008-007705-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007705-37.